Blood Pressure Measures and Incident Primary Open-Angle Glaucoma.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
01 12 2022
Historique:
entrez: 5 12 2022
pubmed: 6 12 2022
medline: 10 12 2022
Statut: ppublish

Résumé

To investigate the association of systemic blood pressure and incident primary open-angle glaucoma (POAG) using a large open-access database. Prospective cohort study included 484,268 participants from the UK Biobank without glaucoma at enrollment. Incident POAG events were recorded through assessment visits, hospital inpatient admissions, and primary care data. Blood pressure measures included systolic blood pressure (SBP), diastolic blood pressure (DBP), pulse pressure (PP), and mean arterial pressure (MAP). Repeated measurements throughout the study period were analyzed as time-varying covariables. The parameters were modeled as both categorical and continuous nonlinear variables. The primary outcome measure was the relative hazard of incident POAG. There were 2390 incident POAG events over 5,715,480 person-years of follow-up. Median follow-up was 12.08 years. In multivariable analyses, compared to SBP and PP in the normal range (SBP, 120-130 mmHg; PP, 40-50 mmHg), higher SBP and PP were associated with an increased risk of incident POAG (linear trend P = 0.038 for SBP, P < 0.001 for PP). Specifically, SBP of 130 to 140 mmHg or 140 to 150 mmHg was associated with a 1.16 higher hazard of incident POAG (95% CI, 1.01-1.32 and 1.01-1.33, respectively), whereas a PP of greater than 70 mmHg was associated with a 1.13 higher hazard of incident glaucoma (95% CI, 1.00-1.29). In multivariable models, no statistically significant associations were found for DBP or MAP with incident glaucoma. These findings were similar when blood pressure measures were modeled as continuous variables. Higher SBP and PP were associated with an increased risk of incident POAG. Further studies are required to characterize these relationships better.

Identifiants

pubmed: 36469027
pii: 2783898
doi: 10.1167/iovs.63.13.3
pmc: PMC9730736
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3

Subventions

Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom
Organisme : NEI NIH HHS
ID : P30 EY026877
Pays : United States

Références

Arch Intern Med. 2000 Oct 9;160(18):2765-72
pubmed: 11025786
Arch Ophthalmol. 2007 Jun;125(6):805-12
pubmed: 17562992
Invest Ophthalmol Vis Sci. 2015 Apr;56(4):2439-48
pubmed: 25758813
Clin Exp Ophthalmol. 2022 Mar;50(2):143-162
pubmed: 35037362
Nat Rev Nephrol. 2020 Apr;16(4):223-237
pubmed: 32024986
Eur J Epidemiol. 2017 Aug;32(8):691-699
pubmed: 28608186
BMC Public Health. 2019 Jul 1;19(1):851
pubmed: 31262269
Curr Opin Cardiol. 2020 Jul;35(4):342-350
pubmed: 32398604
Lancet Glob Health. 2021 Feb;9(2):e144-e160
pubmed: 33275949
Am J Ophthalmol. 2014 Sep;158(3):615-27.e9
pubmed: 24879946
Surv Ophthalmol. 2008 Nov;53 Suppl1:S3-10
pubmed: 19038621
Am J Ophthalmol. 2010 May;149(5):704-12
pubmed: 20399924
Am J Ophthalmol. 2012 Oct;154(4):702-11
pubmed: 22835512
Am J Hypertens. 2015 Sep;28(9):1077-82
pubmed: 25767134
Ophthalmology. 2022 Mar;129(3):276-284
pubmed: 34688700
Am J Cardiol. 1971 Apr;27(4):335-46
pubmed: 5572576
Ophthalmology. 2011 Jul;118(7):1318-26
pubmed: 21481477
Hypertens Res. 2016 Sep;39(9):640-7
pubmed: 27194570
Curr Opin Ophthalmol. 2005 Apr;16(2):101-6
pubmed: 15744140
Ophthalmology. 2007 Nov;114(11):1965-72
pubmed: 17628686
Acta Ophthalmol. 2019 Jun;97(4):e487-e492
pubmed: 30315616
Ophthalmology. 2022 Feb;129(2):161-170
pubmed: 34474070
Invest Ophthalmol Vis Sci. 2003 Sep;44(9):3783-9
pubmed: 12939292
Br J Ophthalmol. 2006 Mar;90(3):262-7
pubmed: 16488940
Am J Epidemiol. 2017 Nov 1;186(9):1026-1034
pubmed: 28641372
Am J Hypertens. 2001 May;14(5 Pt 1):415-8
pubmed: 11368460
J Chronic Dis. 1978 Apr;31(4):201-306
pubmed: 681498
Ophthalmology. 2008 Jan;115(1):85-93
pubmed: 17629563
Arch Intern Med. 2000 Apr 24;160(8):1085-9
pubmed: 10789600
Ann Intern Med. 1978 Mar;88(3):342-5
pubmed: 629496
Br J Ophthalmol. 2016 Jan;100(1):86-93
pubmed: 26286821
Ophthalmology. 2021 Jan;128(1):58-69
pubmed: 32730956
PLoS Med. 2015 Mar 31;12(3):e1001779
pubmed: 25826379
Am J Hypertens. 2021 Sep 22;34(9):929-938
pubmed: 33687055
Arch Ophthalmol. 2002 Jul;120(7):954-9
pubmed: 12096967
Diabetes Metab J. 2020 Jun;44(3):414-425
pubmed: 31950773
Invest Ophthalmol Vis Sci. 2020 Jul 1;61(8):35
pubmed: 32716503
Am J Hypertens. 2019 Feb 12;32(3):308-316
pubmed: 30535341
Prog Retin Eye Res. 2002 Jul;21(4):359-93
pubmed: 12150988
N Engl J Med. 2015 Nov 26;373(22):2103-16
pubmed: 26551272

Auteurs

Carmelo Macri (C)

Discipline of Ophthalmology and Visual Sciences, The University of Adelaide and Royal Adelaide Hospital, Adelaide, South Australia, Australia.

Christopher X Wong (CX)

Department of Cardiology, The University of Adelaide and Royal Adelaide Hospital, Adelaide, South Australia, Australia.

Samuel J Tu (SJ)

Department of Cardiology, The University of Adelaide and Royal Adelaide Hospital, Adelaide, South Australia, Australia.

Robert Casson (R)

Discipline of Ophthalmology and Visual Sciences, The University of Adelaide and Royal Adelaide Hospital, Adelaide, South Australia, Australia.

Kuldev Singh (K)

Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, California, United States.

Sophia Y Wang (SY)

Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, California, United States.

Michelle T Sun (MT)

Discipline of Ophthalmology and Visual Sciences, The University of Adelaide and Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, California, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH